Profiling the genes affected by pathogenic TDP-43 in astrocytes

Journal of Neurochemistry

Volumn 129, Issue 6, 2014, Pages 932-939

  Huang, Cao ^a   Huang, Bo ^b   Bi, Fangfang ^c   Yan, Linda H ^b   Tong, Jianbin ^d   Huang, Jufang ^a   Xia, Xu Gang ^b   Zhou, Hongxia ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

amyotrophic lateral sclerosis; astrocytes; Chi3L1; Lcn2; TDP 43

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SECRETORY PROTEIN; TAR DNA BINDING PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL SURVIVAL; CHITINASE 3 LIKE PROTEIN 1 GENE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; LCN2 GENE; MALE; MICROARRAY ANALYSIS; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC RAT; UPREGULATION;

RATTUS;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTES; CHI3L1; LCN2; TDP-43;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; CELL DEATH; CELL SURVIVAL; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GLYCOPROTEINS; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; MUTATION; NERVE GROWTH FACTORS; NEURONS; POLYMERASE CHAIN REACTION; PRIMARY CELL CULTURE; RATS; RATS, TRANSGENIC;

EID: 84902386479     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12660     Document Type: Article

References (41)

1. Ayala Y. M., Pantano S., D'Ambrogio A., Buratti E., Brindisi A., Marchetti C., Romano M., and, Baralle F. E., (2005) Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 348, 575-588.
2. Ayala Y. M., Zago P., D'Ambrogio A., Xu Y. F., Petrucelli L., Buratti E., and, Baralle F. E., (2008) Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121, 3778-3785.
3. Bi F., Huang C., Tong J., et al,. (2013) Reactive astrocytes secrete lcn2 to promote neuron death. Proc. Natl Acad. Sci. USA 110, 4069-4074.
4. Bonneh-Barkay D., Wang G., Starkey A., Hamilton R. L., and, Wiley C. A., (2010) In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J. Neuroinflammation 7, 34.
5. Buratti E., and, Baralle F. E., (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276, 36337-36343.
6. Buratti E., Brindisi A., Giombi M., Tisminetzky S., Ayala Y. M., and, Baralle F. E., (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280, 37572-37584.
7. Craig-Schapiro R., Perrin R. J., Roe C. M., et al,. (2010) YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol. Psychiatry 68, 903-912.
8. Custer S. K., Garden G. A., Gill N., et al,. (2006) Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat. Neurosci. 9, 1302-1311.
9. Dobolyi A., and, Palkovits M., (2008) Expression of latent transforming growth factor beta binding proteins in the rat brain. J. Comp. Neurol. 507, 1393-1408.
10. Escartin C., and, Bonvento G., (2008) Targeted activation of astrocytes: a potential neuroprotective strategy. Mol. Neurobiol. 38, 231-241.
11. Howland D. S., Liu J., She Y., et al,. (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl Acad. Sci. USA 99, 1604-1609.
12. Huang C., Tong J., Bi F., Wu Q., Huang B., Zhou H., and, Xia X. G., (2012a) Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats. Hum. Mol. Genet. 21, 4602-4614.
13. Huang C., Tong J., Bi F., Zhou H., and, Xia X. G., (2012b) Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats. J. Clin. Invest. 122, 107-118.
14. Igaz L. M., Kwong L. K., Lee E. B., et al,. (2011) Dysregulation of the ALS-Associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Invest. 121, 726-738.
15. Kabashi E., Valdmanis P. N., Dion P., et al,. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574.
16. Kwong L. K., Neumann M., Sampathu D. M., Lee V. M., and, Trojanowski J. Q., (2007) TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol. 114, 63-70.
17. Kwong L. K., Uryu K., Trojanowski J. Q., and, Lee V. M., (2008) TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Neurosignals 16, 41-51.
18. Landreth G., Jiang Q., Mandrekar S., and, Heneka M., (2008) PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics 5, 481-489.
19. Lee S., Lee J., Kim S., Park J. Y., Lee W. H., Mori K., Kim S. H., Kim I. K., and, Suk K., (2007) A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 179, 3231-3241.
20. Lee S., Park J. Y., Lee W. H., Kim H., Park H. C., Mori K., and, Suk K., (2009) Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 29, 234-249.
21. Lepore A. C., Rauck B., Dejea C., Pardo A. C., Rao M. S., Rothstein J. D., and, Maragakis N. J., (2008) Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 11, 1294-1301.
22. Liu A., Zhuang Z., Hoffman P. W., and, Bai G., (2003) Functional analysis of the rat N-methyl-D-Aspartate receptor 2A promoter: multiple transcription starts points, positive regulation by Sp factors, and translational regulation. J. Biol. Chem. 278, 26423-26434.
23. Lobsiger C. S., and, Cleveland D. W., (2007) Glial cells as intrinsic components of non-cell-Autonomous neurodegenerative disease. Nat. Neurosci. 10, 1355-1360.
24. Nagai M., Re D. B., Nagata T., Chalazonitis A., Jessell T. M., Wichterle H., and, Przedborski S., (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615-622.
25. Neumann M., Sampathu D. M., Kwong L. K., et al,. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.
26. Okada S., Nakamura M., Katoh H., et al,. (2006) Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 12, 829-834.
27. Pesiridis G. S., Lee V. M., and, Trojanowski J. Q., (2009) Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, R156-R162.
28. Rothstein J. D., Dykes-Hoberg M., Pardo C. A., et al,. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
29. Rutherford N. J., Zhang Y. J., Baker M., et al,. (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 4, e1000193.
30. Sephton C. F., Cenik C., Kucukural A., et al,. (2011) Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem. 286, 1204-1215.
31. Sephton C. F., Cenik B., Cenik B. K., Herz J., and, Yu G., (2012) TDP-43 in central nervous system development and function: clues to TDP-43-Associated neurodegeneration. Biol. Chem. 393, 589-594.
32. Serio A., Bilican B., Barmada S. J., et al,. (2013) Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl Acad. Sci. USA 110, 4697-4702.
33. Sreedharan J., Blair I. P., Tripathi V. B., et al,. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672.
34. Swarup V., Phaneuf D., Dupre N., Petri S., Strong M., Kriz J., and, Julien J. P., (2011) Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J. Exp. Med. 208, 2429-2447.
35. Tong J., Huang C., Bi F., Wu Q., Huang B., and, Zhou H., (2012) XBP1 depletion precedes ubiquitin aggregation and Golgi fragmentation in TDP-43 transgenic rats. J. Neurochem. 123, 406-416.
36. Tong J., Huang C., Bi F., Wu Q., Huang B., Liu X., Li F., Zhou H., and, Xia X. G., (2013) Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-Autonomous motor neuron death in rats. EMBO J. 32, 1917-1926.
37. Tsai K. J., Yang C. H., Fang Y. H., Cho K. H., Chien W. L., Wang W. T., Wu T. W., Lin C. P., Fu W. M., and, Shen C. K., (2010) Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J. Exp. Med. 207, 1661-1673.
38. Van Deerlin V. M., Leverenz J. B., Bekris L. M., et al,. (2008) TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7, 409-416.
39. Wang H. Y., Wang I. F., Bose J., and, Shen C. K., (2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83, 130-139.
40. van Weering H. R., Boddeke H. W., Vinet J., Brouwer N., de Haas A. H., van Rooijen N., Thomsen A. R., and, Biber K. P., (2011) CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus 21, 220-232.
41. Zhou H., Huang C., Chen H., Wang D., Landel C. P., Xia P. Y., Bowser R., Liu Y. J., and, Xia X. G., (2010) transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet. 6, e1000887.